Bausch Health loses $350M in Q3 — 5 insights

Written by Eric Oliver | November 08, 2018 | Print  |

Bausch Health reported a $350 million loss in the third quarter of 2018.

Here's what you should know:

1. Bausch reported total revenues of $2.14 billion for the quarter, down from the $2.22 billion the company reported last year.

2. The company's Bausch + Lomb brand revenues slipped 7 percent from $1.23 billion in 2017 to $1.15 billion in 2018, which the company said was due to divestitures and discontinuations.

3. The company's gastroenterology segment, Salix, grew 2 percent from $452 million in 2017 to $460 million in 2018.

4. Bausch Health CEO Joseph C. Papa said in a press release, "These results demonstrate that our progress toward transformation is on track as we continue to execute within our core businesses, launch new products, resolve legacy issues and reduce the total quantum of our debt."

5. Bausch maintained its 2018 full-year forecast. The company expects to report revenues between $8.15 and $8.35 billion.

More articles on supply chain:
Texas Digestive Disease Consultants finds PE partner, forms GI practice management company
10 ASC developments costing $10M+ — October 2018
Turkey attacks, in-law mishaps & more: 20 ICD-10 codes to know for Thanksgiving

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.